Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Polycythemia Vera
Related studies linked through entity extraction aliases.
Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib in Polycythemia Vera
- Status
- TERMINATED
- Phase
- PHASE2
A Safety Study of XL019 in Adults With Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE1
Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- NA
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
- Status
- COMPLETED
- Phase
- N/A
Effects of Imatinib Mesylate in Polycythemia Vera
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE2
3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
- Status
- COMPLETED
- Phase
- NA
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
- Status
- COMPLETED
- Phase
- PHASE2
Imatinib Mesylate in Treating Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
- Status
- COMPLETED
- Phase
- NA